J. Scott Wolchko - Jan 10, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jan 10, 2022
Transactions value $
-$1,600,534
Form type
4
Date filed
1/12/2022, 03:07 PM
Previous filing
Nov 22, 2021
Next filing
Jan 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale -$610K -13.2K -2.74% $46.36* 467K Jan 10, 2022 Direct F1, F2
transaction FATE Common Stock Sale -$986K -20.9K -4.47% $47.17* 446K Jan 10, 2022 Direct F1, F3
transaction FATE Common Stock Sale -$4.82K -101 -0.02% $47.72* 446K Jan 10, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 62,500 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 Represents the weighted average sale price of the shares sold ranging from $45.72 to $46.70 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3.
F3 Represents the weighted average sale price of the shares sold ranging from $46.72 to $47.67 per share.